Updated diagnosis and treatment of childhood tuberculosis
- First Online:
Childhood tuberculosis (TB) accounts for a significant proportion of the global tuberculosis disease burden. However, current and previous efforts to develop better diagnostic, therapeutic, and preventive interventions have focused on TB in adults, and childhood TB has been relatively neglected. The purpose of this review is to provide an update on the diagnostic and therapeutic recommendations for childhood TB with an emphasis on intrathoracic disease.
The literature from a range of sources was reviewed and synthesized to provide an overview of the contemporary approaches for the diagnosis and treatment of childhood TB.
This review summarizes the clinical, radiological, bacteriological, and immunological approaches to diagnose TB infection and disease in children. In addition, we summarize the updated guidelines for the treatment of TB in children.
The development of better diagnostic and therapeutic methods for childhood TB remains a significant challenge. As the strategies for diagnosis and treatment of childhood TB continue to improve and the knowledge base increases, the implementation of these strategies will be crucial.
Key wordschildhood diagnosis treatment tuberculosis
Unable to display preview. Download preview PDF.
- 1.WHO Report. Global tuberculosis control. Epidemiology, strategy, financing. Geneva: World Health Organization, 2009.Google Scholar
- 19.Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis 2006;10:1091–1097.Google Scholar
- 20.Centers for Disease Control. Taiwan Guidelines for TB Diagnosis and Treatment. Centers for Disease Control, Taiwan, 2011.Google Scholar
- 22.Piñeiro R, Cilleruelo MJ, Mellado MJ. Indications and interpretation of tuberculin skin test. Form Act Pediatr Aten Prim 2010;3:114–116.Google Scholar
- 23.Piñeiro R, Cilleruelo MJ, García-Hortelano M, García-Ascaso M, Medina-Claros A, Mellado MJ. Effect of nutritional status on tuberculin skin testing. Indian J Pediatr 2012; DOI:10.1007/ s12098-012-0773-1.Google Scholar
- 31.Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009;28:669–673.PubMedCrossRefGoogle Scholar
- 45.Gómez-Pastrana D, Carceller-Blanchard A. Should pulmonary computed tomography be performed in children with tuberculosis infection without apparent disease? An Pediatr (Barc) 2007;67:585–593.Google Scholar
- 50.Ba F, Rieder HL. A comparison of fluorescence microscopy with the Ziehl-Neelsen technique in the examination of sputum for acid-fast bacilli. Int J Tuberc Lung 1999;3:1101–1105.Google Scholar
- 59.World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization, 2008.Google Scholar
- 62.World Health Organization. Rapid advice: treatment of tuberculosis in children. World Health Organization, Geneva, Switzerland, 2010.Google Scholar
- 63.Jassal MS, Aldrovandi GM. 2050: Ending the odyssey of the great white plague. Pharmacol Res 2011;64:176–17Google Scholar
- 68.Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV infected children: recommendations for a public health approach, 2010. Paris: International Union Against Tuberculosis and Lung Disease, 2010.Google Scholar
- 69.Migliori GB, Sotgiu G, Gandhi NR, Falzon D, Deriemer K, Centis R, et al. Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis. Eur Respir J 2012; DOI: 10.1183/09031936.00136312.Google Scholar
- 75.WHO. Guidelines for the programmatic management of drugresistant tuberculosis. Geneva: World Health Organization, 2006. http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf (accessed June 19, 2008).Google Scholar
- 76.World Health Organization. Report of the meeting on TB medicines for children-July 2008. World Health Organization, Geneva, 2008. http://who.int/selection_medicines/committes/subcommittee/2/en/index.html (accessed June 19, 2012).Google Scholar
- 77.American Thoracic Society and Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1–51.Google Scholar
- 80.Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 2007;45:715–722.PubMedCrossRefGoogle Scholar